IBDEI2KY ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43795,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,43795,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,43795,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,43796,0)
 ;;=R31.0^^170^2106^3
 ;;^UTILITY(U,$J,358.3,43796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43796,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,43796,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,43796,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,43797,0)
 ;;=R31.1^^170^2106^2
 ;;^UTILITY(U,$J,358.3,43797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43797,1,3,0)
 ;;=3^Hematuria,Benign Essential Microscopic
 ;;^UTILITY(U,$J,358.3,43797,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,43797,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,43798,0)
 ;;=R31.2^^170^2106^4
 ;;^UTILITY(U,$J,358.3,43798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43798,1,3,0)
 ;;=3^Hematuria,Microscopic,Other
 ;;^UTILITY(U,$J,358.3,43798,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,43798,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,43799,0)
 ;;=N39.3^^170^2106^7
 ;;^UTILITY(U,$J,358.3,43799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43799,1,3,0)
 ;;=3^Incontinence,Stress
 ;;^UTILITY(U,$J,358.3,43799,1,4,0)
 ;;=4^N39.3
 ;;^UTILITY(U,$J,358.3,43799,2)
 ;;=^5015679
 ;;^UTILITY(U,$J,358.3,43800,0)
 ;;=N39.41^^170^2106^8
 ;;^UTILITY(U,$J,358.3,43800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43800,1,3,0)
 ;;=3^Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,43800,1,4,0)
 ;;=4^N39.41
 ;;^UTILITY(U,$J,358.3,43800,2)
 ;;=^5015680
 ;;^UTILITY(U,$J,358.3,43801,0)
 ;;=N39.46^^170^2106^6
 ;;^UTILITY(U,$J,358.3,43801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43801,1,3,0)
 ;;=3^Incontinence,Mixed
 ;;^UTILITY(U,$J,358.3,43801,1,4,0)
 ;;=4^N39.46
 ;;^UTILITY(U,$J,358.3,43801,2)
 ;;=^5015685
 ;;^UTILITY(U,$J,358.3,43802,0)
 ;;=A63.0^^170^2107^14
 ;;^UTILITY(U,$J,358.3,43802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43802,1,3,0)
 ;;=3^Anogenital Warts,Venereal
 ;;^UTILITY(U,$J,358.3,43802,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,43802,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,43803,0)
 ;;=A56.02^^170^2107^25
 ;;^UTILITY(U,$J,358.3,43803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43803,1,3,0)
 ;;=3^Chlamydial Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,43803,1,4,0)
 ;;=4^A56.02
 ;;^UTILITY(U,$J,358.3,43803,2)
 ;;=^5000340
 ;;^UTILITY(U,$J,358.3,43804,0)
 ;;=B37.3^^170^2107^18
 ;;^UTILITY(U,$J,358.3,43804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43804,1,3,0)
 ;;=3^Candidiasis of Vulva & Vagina
 ;;^UTILITY(U,$J,358.3,43804,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,43804,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,43805,0)
 ;;=A59.01^^170^2107^87
 ;;^UTILITY(U,$J,358.3,43805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43805,1,3,0)
 ;;=3^Trichomonal Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,43805,1,4,0)
 ;;=4^A59.01
 ;;^UTILITY(U,$J,358.3,43805,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,43806,0)
 ;;=D25.9^^170^2107^60
 ;;^UTILITY(U,$J,358.3,43806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43806,1,3,0)
 ;;=3^Leiomyoma of Uterus,Unspec
 ;;^UTILITY(U,$J,358.3,43806,1,4,0)
 ;;=4^D25.9
 ;;^UTILITY(U,$J,358.3,43806,2)
 ;;=^5002081
 ;;^UTILITY(U,$J,358.3,43807,0)
 ;;=D06.9^^170^2107^19
 ;;^UTILITY(U,$J,358.3,43807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43807,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Unspec
 ;;^UTILITY(U,$J,358.3,43807,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,43807,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,43808,0)
 ;;=D06.0^^170^2107^20
 ;;^UTILITY(U,$J,358.3,43808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43808,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,43808,1,4,0)
 ;;=4^D06.0
